Home Treatment Compared to Initial Hospitalization in Normotensive Patients with Acute Pulmonary Embolism in the Netherlands : A Cost Analysis
Thieme. All rights reserved..
BACKGROUND: Venous thromboembolism constitutes substantial health care costs amounting to approximately 60 million euros per year in the Netherlands. Compared with initial hospitalization, home treatment of pulmonary embolism (PE) is associated with a cost reduction. An accurate estimation of cost savings per patient treated at home is currently lacking.
AIM: The aim of this study was to compare health care utilization and costs during the first 3 months after a PE diagnosis in patients who are treated at home versus those who are initially hospitalized.
METHODS: Patient-level data of the YEARS cohort study, including 383 normotensive patients diagnosed with PE, were used to estimate the proportion of patients treated at home, mean hospitalization duration in those who were hospitalized, and rates of PE-related readmissions and complications. To correct for baseline differences within the two groups, regression analyses was performed. The primary outcome was the average total health care costs during a 3-month follow-up period for patients initially treated at home or in hospital.
RESULTS: Mean hospitalization duration for the initial treatment was 0.69 days for those treated initially at home (n = 181) and 4.3 days for those initially treated in hospital (n = 202). Total average costs per hospitalized patient were €3,209 and €1,512 per patient treated at home. The adjusted mean difference was €1,483 (95% confidence interval: €1,181-1,784).
CONCLUSION: Home treatment of hemodynamically stable patients with acute PE was associated with an estimated net cost reduction of €1,483 per patient. This difference underlines the advantage of triage-based home treatment of these patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:122 |
|---|---|
| Enthalten in: |
Thrombosis and haemostasis - 122(2022), 3 vom: 26. März, Seite 427-433 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hendriks, Stephan V [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 22.03.2022 Date Revised 09.08.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1055/a-1518-1847 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM325906092 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM325906092 | ||
| 003 | DE-627 | ||
| 005 | 20231225193434.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1055/a-1518-1847 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1086.xml |
| 035 | |a (DE-627)NLM325906092 | ||
| 035 | |a (NLM)34041736 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hendriks, Stephan V |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Home Treatment Compared to Initial Hospitalization in Normotensive Patients with Acute Pulmonary Embolism in the Netherlands |b A Cost Analysis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.03.2022 | ||
| 500 | |a Date Revised 09.08.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Thieme. All rights reserved. | ||
| 520 | |a BACKGROUND: Venous thromboembolism constitutes substantial health care costs amounting to approximately 60 million euros per year in the Netherlands. Compared with initial hospitalization, home treatment of pulmonary embolism (PE) is associated with a cost reduction. An accurate estimation of cost savings per patient treated at home is currently lacking | ||
| 520 | |a AIM: The aim of this study was to compare health care utilization and costs during the first 3 months after a PE diagnosis in patients who are treated at home versus those who are initially hospitalized | ||
| 520 | |a METHODS: Patient-level data of the YEARS cohort study, including 383 normotensive patients diagnosed with PE, were used to estimate the proportion of patients treated at home, mean hospitalization duration in those who were hospitalized, and rates of PE-related readmissions and complications. To correct for baseline differences within the two groups, regression analyses was performed. The primary outcome was the average total health care costs during a 3-month follow-up period for patients initially treated at home or in hospital | ||
| 520 | |a RESULTS: Mean hospitalization duration for the initial treatment was 0.69 days for those treated initially at home (n = 181) and 4.3 days for those initially treated in hospital (n = 202). Total average costs per hospitalized patient were €3,209 and €1,512 per patient treated at home. The adjusted mean difference was €1,483 (95% confidence interval: €1,181-1,784) | ||
| 520 | |a CONCLUSION: Home treatment of hemodynamically stable patients with acute PE was associated with an estimated net cost reduction of €1,483 per patient. This difference underlines the advantage of triage-based home treatment of these patients | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a van den Hout, Wilbert B |e verfasserin |4 aut | |
| 700 | 1 | |a van Bemmel, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Bistervels, Ingrid M |e verfasserin |4 aut | |
| 700 | 1 | |a Eijsvogel, Michiel |e verfasserin |4 aut | |
| 700 | 1 | |a Faber, Laura M |e verfasserin |4 aut | |
| 700 | 1 | |a Hofstee, Herman M A |e verfasserin |4 aut | |
| 700 | 1 | |a van der Hulle, Tom |e verfasserin |4 aut | |
| 700 | 1 | |a Iglesias Del Sol, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Kruip, Marieke J H A |e verfasserin |4 aut | |
| 700 | 1 | |a Mairuhu, Albert T A |e verfasserin |4 aut | |
| 700 | 1 | |a Middeldorp, Saskia |e verfasserin |4 aut | |
| 700 | 1 | |a Nijkeuter, Mathilde |e verfasserin |4 aut | |
| 700 | 1 | |a Huisman, Menno V |e verfasserin |4 aut | |
| 700 | 1 | |a Klok, Frederikus A |e verfasserin |4 aut | |
| 700 | 0 | |a YEARS Investigators |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Thrombosis and haemostasis |d 1979 |g 122(2022), 3 vom: 26. März, Seite 427-433 |w (DE-627)NLM000103896 |x 2567-689X |7 nnns |
| 773 | 1 | 8 | |g volume:122 |g year:2022 |g number:3 |g day:26 |g month:03 |g pages:427-433 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1055/a-1518-1847 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 122 |j 2022 |e 3 |b 26 |c 03 |h 427-433 | ||